Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 820-823, February 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, R.
Right arrow Articles by Nakamura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, R.
Right arrow Articles by Nakamura, Y.

Allelotype of Renal Cell Carcinoma1

Ryoji Morita, Jiro Ishikawa, Masayoshi Tsutsumi, Kazumasa Hikiji, Yutaka Tsukada, Sadao Kamidono, Sakan Maeda and Yusuke Nakamura2

Department of Biochemistry, Cancer Institute [R. M., Y. N.], Department of Genetic Research Laboratory, SRL Incorporation [R. M., M. T., K. H., Y. T.], Department of Urology, Kobe National Hospital [J. I.], Department of Urology [S. K.], Department of Pathology [S. M.], Kobe University, School of Medicine, Tokyo, Japan

Several recent studies based on restriction fragment length polymorphism analysis have supported the concept that the accumulation of multiple genetic alterations converts a normal cell to a malignant cell. Activation of oncogenes and/or inactivation of tumor suppressor genes have been observed during tumor progression in colorectal cancer, lung cancer, and breast cancer. To investigate the possibility that multiple genes are altered during the progression of renal cell carcinoma, we have used restriction fragment length polymorphism markers throughout the genome to test for loss of heterozygosity in 38 renal cell carcinomas. Nearly 64% of the tumors had lost heterozygosity on the short arm of chromosome 3. We also observed loss of heterozygosity averaging about 30% at informative loci on six other chromosomal arms (chromosomes 5q, 6q, 10q, 11q, 17p, and 19p). These results lead us to suspect the existence of several tumor suppressor genes associated with carcinogenesis of renal cell carcinoma.

1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed, at Department of Biochemistry, Cancer Institute, 1-37-1, Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan.

Received 8/31/90. Accepted 11/12/90.




This article has been cited by other articles:


Home page
Cancer Res.Home page
I. Ibanez de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, and P. Cairns
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Cancer Res., May 15, 2006; 66(10): 5021 - 5028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sarkar, B. C. Roy, N. Hatano, T. Aoyagi, K. Gohji, and R. Kiyama
A Novel Ankyrin Repeat-containing Gene (Kank) Located at 9p24 Is a Growth Suppressor of Renal Cell Carcinoma
J. Biol. Chem., September 20, 2002; 277(39): 36585 - 36591.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Morrissey, A. Martinez, M. Zatyka, A. Agathanggelou, S. Honorio, D. Astuti, N. V. Morgan, H. Moch, F. M. Richards, T. Kishida, et al.
Epigenetic Inactivation of the RASSF1A 3p21.3 Tumor Suppressor Gene in Both Clear Cell and Papillary Renal Cell Carcinoma
Cancer Res., October 1, 2001; 61(19): 7277 - 7281.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Jiang, R. Desper, C. H. Papadimitriou, A. A. Schäffer, O.-P. Kallioniemi, J. Richter, P. Schraml, G. Sauter, M. J. Mihatsch, and H. Moch
Construction of Evolutionary Tree Models for Renal Cell Carcinoma from Comparative Genomic Hybridization Data
Cancer Res., November 1, 2000; 60(22): 6503 - 6509.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
Y. Harima, K. Harima, S. Sawada, Y. Tanaka, S. Arita, and T. Ohnishi
Loss of Heterozygosity on Chromosome 6p21.2 as a Potential Marker for Recurrence after Radiotherapy of Human Cervical Cancer
Clin. Cancer Res., March 1, 2000; 6(3): 1079 - 1085.
[Abstract] [Full Text]


Home page
BloodHome page
Y. Hatta, Y. Yamada, M. Tomonaga, I. Miyoshi, J. W. Said, and H. P. Koeffler
Detailed Deletion Mapping of the Long Arm of Chromosome 6 in Adult T-Cell Leukemia
Blood, January 15, 1999; 93(2): 613 - 616.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Hatta, Y. Yamada, M. Tomonaga, J. W. Said, I. Miyosi, and H. P. Koeffler
Allelotype Analysis of Adult T-Cell Leukemia
Blood, September 15, 1998; 92(6): 2113 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Genome Res.Home page
W Bardenheuer, S Michaelis, A Lux, L Vieten, F Brocker, K Julicher, C Willers, R Siebert, D I Smith, A H van der Hout, et al.
Construction of a consistent YAC contig for human chromosome region 3p14.1.
Genome Res., March 1, 1996; 6(3): 176 - 186.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.